EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study

Erwin A van Vliet iD, Mirte Scheper iD, James D Mills iD, Noora Puhakka iD, Kinga Szydlowska iD, Manuela Ferracin iD, Francesca Lovisari iD, Marie Soukupova iD, Silvia Zucchini iD, Prashant K Srivastava iD, Michael R Johnson iD, Katarzyna Lukasiuk iD und 4 weitere

Epilepsia · 2024

DOI: 10.1111/epi.18134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Erwin A van Vliet und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of (Neuro)pathology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Epilepsy, Disease Models, Animal, Biomarkers, Circulating MicroRNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Seventh Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Structural epilepsies can manifest months or years after the occurrence of an initial epileptogenic insult, making them amenable for secondary prevention. However, development of preventive treatments has been challenged by a lack of biomarkers for identifying the subset of individuals with the highest risk of epilepsy after the epileptogenic insult.

Methods

Four different rat models of epileptogenesis were investigated to identify differentially expressed circulating microRNA (miRNA) and isomiR profiles as biomarkers for epileptogenesis. Plasma samples were collected on day 2 and day 9 during the latency period from animals that did or did not develop epilepsy during long‐term video‐electroencephalographic monitoring. miRNAs and isomiRs were identified and measured in an unsupervised manner, using a genome‐wide small RNA sequencing platform. Receiver operating characteristic analysis was performed to determine the performance of putative biomarkers.

Results

Two days after an epileptogenic insult, alterations in the levels of several plasma miRNAs and isomiRs predicted epileptogenesis in a model‐specific manner. One miRNA, miR‐3085, showed good sensitivity (but low specificity) as a prognostic biomarker for epileptogenesis in all four models (area under the curve = .729, sensitivity = 83%, specificity = 64%, p < .05). Significance Identified plasma miRNAs and isomiRs are mostly etiology‐specific rather than common prognostic biomarkers of epileptogenesis. These data imply that in preclinical and clinical studies, it may be necessary to identify specific biomarkers for different epilepsy etiologies. Importantly, circulating miRNAs like miR‐3085 with high negative predictive value for epileptogenesis in different etiologies could be useful candidates for initial screening purposes of epileptogenesis risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyDisease Models, AnimalBiomarkersCirculating MicroRNAAnimalsRatsMaleElectroencephalographyMicroRNAsRats, Sprague-DawleyKainic Acid

Stichwörter der Autor:innen

amygdala stimulationperforant pathway stimulationpilocarpineposttraumatic epilepsystatus epilepticustraumatic brain injury

Substanzen

BiomarkersCirculating MicroRNAMicroRNAsKainic Acid

Autor:innen und Institutionen

  • Department of (Neuro)pathology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
  • Chalfont Centre for Epilepsy, Buckinghamshire, UK.
  • A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Laboratory of Epileptogenesis, Nencki Institute of Experimental Biology, Warsaw, Poland.

ORCID-Profile: Erwin A van Vliet, Mirte Scheper, James D Mills, Noora Puhakka, Kinga Szydlowska, Manuela Ferracin, Francesca Lovisari, Marie Soukupova, Silvia Zucchini, Prashant K Srivastava, Michael R Johnson, Katarzyna Lukasiuk, Jan A Gorter, Eleonora Aronica, Asla Pitkänen, Michele Simonato

Förderung

  • Seventh Framework Programme

Zitieren

APA

van Vliet, E. A., Scheper, M., Mills, J. D., Puhakka, N., Szydlowska, K., Ferracin, M., Lovisari, F., Soukupova, M., Zucchini, S., Srivastava, P. K., Johnson, M. R., Lukasiuk, K., Gorter, J. A., Aronica, E., Pitkänen, A., & Simonato, M. (2024). Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study. Epilepsia. https://doi.org/10.1111/epi.18134

Vancouver

van Vliet EA, Scheper M, Mills JD, Puhakka N, Szydlowska K, Ferracin M, et al. Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study. Epilepsia. 2024. doi:10.1111/epi.18134

BibTeX
@article{vanVliet2024,
  author = {van Vliet, Erwin A and Scheper, Mirte and Mills, James D and Puhakka, Noora and Szydlowska, Kinga and Ferracin, Manuela and Lovisari, Francesca and Soukupova, Marie and Zucchini, Silvia and Srivastava, Prashant K and Johnson, Michael R and Lukasiuk, Katarzyna and Gorter, Jan A and Aronica, Eleonora and Pitkänen, Asla and Simonato, Michele},
  title = {Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.18134}
}
Kostenlos starten →